David Johnson
2020 - Global Blood Therapeutics
In 2020, David Johnson earned a total compensation of $6.3M as Chief Commercial Officer at Global Blood Therapeutics, a 98% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $1,582,504 |
| Salary | $463,750 |
| Stock Awards | $4,037,361 |
| Other | $5,000 |
| Total | $6,322,615 |
Johnson received $4M in stock awards, accounting for 64% of the total pay in 2020.
Johnson also received $234K in non-equity incentive plan, $1.6M in option awards, $463.8K in salary and $5K in other compensation.
Rankings
In 2020, David Johnson's compensation ranked 1,625th out of 13,090 executives tracked by ExecPay. In other words, Johnson earned more than 87.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,625 out of 13,090 | 88th |
Division Manufacturing | 614 out of 5,618 | 89th |
Major group Chemicals And Allied Products | 220 out of 2,251 | 90th |
Industry group Drugs | 183 out of 1,951 | 91st |
Industry Pharmaceutical Preparations | 128 out of 1,456 | 91st |
Pay ratio
| David Johnson's Pay | $6,322,615 |
|---|---|
| Median Employee's Pay | $373,366 |
| Pay Ratio | 17to 1 |
In 2020, the annual total compensation of David Johnson was $6,322,615.
The annual total compensation of the median employee at Global Blood Therapeutics was $373,366.
The ratio of David Johnson's pay to the pay of median employee was therefore 17 to one.
Source: SEC filing on April 28, 2021.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2020.